ViroVet · Company in Belgium Tech

Overview

ViroVet is a company dedicated to developing technologies for viral disease control in livestock. The company's pipeline includes antiviral drugs for respiratory disease complexes and PLLAV vaccines—modified live virus vaccines that eliminate cold chain requirements. ViroVet has antiviral solutions for diseases like BVD and ASF.

In the news

ViroVet 2016 – 2026 Yesterday we closed the doors of ViroVet. Not with regret, but with pride in what this team built over ten years — and with gratitude to everyone who was part of it. We set out to develop better tools to combat viral diseases in livestock. What followed was a decade of science that speaks for itself. Together with The Pirbright Institute, we were the first in the world to demonstrate efficacy of antiviral drugs in African swine fever-infected pigs. Our PLLAV vaccine platform, developed in close collaboration withLinkedIn · 26 Jun 2026

YLeuvenLocation

Something wrong or missing? Send an update. Fixed within 24 hours.

Overview

In the news

Related profiles